Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response

ConclusionsNo relationship was identified between symptomatic benefit and response by RECIST 1.1 on MRI. Prospective studies in AF should incorporate endpoints focusing on patient symptoms.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research